Variant Ii Hemoglobin A1C Program With Models 270-2101NU
Assay, Glycosylated Hemoglobin. 510(k) K070452, from Bio-Rad Laboratories, Inc. (Hercules, CA). Product code LCP, class 2.
As of Nov 20, 2026, K070452 is an FDA 510(k) held by Bio-Rad Laboratories, Inc., substantially equivalent on May 7, 2007 after 80 days, with 1 recall tied to it in FDA's recall database.
- Review time: 80 days
- Recalls: 1
- Cited as a predicate by: 4 devices
The Bio-Rad VARIANT II Hemoglobin A1c Program is intended for the percent determination of hemoglobin A1c in human whole blood using ion-exchange high-performance liquid chromatography (HPLC). The Bio-Rad VARIANT II Hemoglobin A1c Program is intended for Professional Use Only.
- Variant Ii Hemoglobin A1C ProgramK984268 · Bio-Rad · Dec 17, 1998
- D-100 HbA1c, D-100 HbA1c Calibrator PackK151321 · Bio-Rad Laboratories, Inc. · Dec 9, 2015
- Variant Ii Hemoglobin A1C Program (New), Variant Ii Hemoglobin Testing System With Cdm Software, Cdm SoftwareK130860 · Bio-Rad Laboratories, Inc., Clinical Systems Divis · Apr 25, 2013
- Dimensions HB1C Kit, Model DF105AK102510 · Siemens Healthcare Diagnostics · May 13, 2011
- Hemoglobin Capillary Collection System (Hccs), 1 Test, Hemoglobin Capillary Collection System (Hccs), 5 Tests, HemoglobiK090737 · Bio-Rad Laboratories, Inc. · Jun 3, 2009
| Started | Recall | Status |
|---|---|---|
| Jun 15, 2009 | Z-1013-2010Calibration Failure-- due to high intercept values, the device fails calibration and users are unable to run samples. | Terminated |
- Q-Pad Test SystemK231465 · Qurasense · Dec 6, 2023
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Feb 16, 2007
- Review panel
- Hematology
- Regulation
- 21 CFR 864.7470
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files